Imunon
Clinical trials sponsored by Imunon, explained in plain language.
-
New drug combo aims to wipe out hidden cancer cells
Disease control Recruiting nowThis study is testing if adding an experimental drug called IMNN-001 to standard chemotherapy and bevacizumab is safe and more effective at controlling advanced ovarian, fallopian tube, or primary peritoneal cancer. Researchers will compare the two-drug standard treatment to the …
Phase: PHASE1, PHASE2 • Sponsor: Imunon • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
New hope for advanced ovarian cancer: major trial tests drug to boost chemo
Disease control Recruiting nowThis large Phase 3 trial is testing whether adding a new drug called IMNN-001 to standard chemotherapy helps people with advanced ovarian, fallopian tube, or primary peritoneal cancer live longer. About 500 participants will be randomly assigned to receive either the standard che…
Phase: PHASE3 • Sponsor: Imunon • Aim: Disease control
Last updated Mar 09, 2026 14:24 UTC